Cambridge Investment Research Advisors’s KORU Medical Systems KRMD Stock Holding History

Cambridge Investment Research Advisors’s Portfolio KRMD Stock Details KRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-23,250	Closed	-$140K	–	2940
2020 Q4	$140K	Sell	23,250 -8,311	-26%	-$46.5K	﹤0.01%	2549
2020 Q3	$228K	Buy	31,561 +5,357	+20%	+$47.5K	﹤0.01%	2149
2020 Q2	$235K	Buy	26,204 +9,672	+59%	+$97.8K	﹤0.01%	2069
2020 Q1	$124K	Buy	+16,532	New	+$111K	﹤0.01%	2068

Other funds holding KRMD

HCM

Horton Capital Management Philadelphia, Pennsylvania $44.9M AUM 24.87% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Cambridge Investment Research Advisors's KRMD Position: Q1 2021 in Review

Cambridge Investment Research Advisors sold out of KORU Medical Systems (KRMD) in Q1 2021, closing a stake of 23,250 shares — an estimated $140K sold.

Cambridge Investment Research Advisors first reported a position in KRMD in Q1 2020 and held it in 4 quarters. The position peaked at $235K in Q2 2020. 72 funds tracked by Wall St. Rank hold KRMD as of Q1 2021.

Cambridge Investment Research Advisors reported no remaining KORU Medical Systems position as of Q1 2021 after selling out during the quarter.
Cambridge Investment Research Advisors sold 23,250 KORU Medical Systems shares in Q1 2021, an estimated $140K.
Cambridge Investment Research Advisors first reported a position in KORU Medical Systems in Q1 2020 and held it in 4 quarters.
Cambridge Investment Research Advisors's KORU Medical Systems position peaked at $235K in Q2 2020.
72 funds tracked by Wall St. Rank held KORU Medical Systems as of Q1 2021.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2021, filed 7 May 2021.